Mohammad A. Vasef, M.D.

photo of Mohammad Vasef

Professor

Email: MVasef@salud.unm.edu


Interests:

  • Molecular Pathogenesis of Hematopoietic Tumors
  • Next generation sequencing and changing role of pathology practice
  • Molecular Genetic Pathology Fellowship Training
  • Hematopathology

Education and Certification Information

Fellowship:
Hematopathology
City of Hope National Medical Center
Duarte, CA
1994-1997

Residency:
Anatomic & Clinical Pathology
Mt. Sinai Medical Center/Case Western Reserve University
Cleveland, OH
1990-1994

Medical School:
University of Tehran School of Medicine
1981

Board Certifications:
American Board of Pathology in Anatomic and Clinical Pathology (1996)
American Board of Pathology in Hematology (1997)
American Board of Pathology and the American Board of Medical Genetics in Molecular Genetic Pathology (2007)


Selected Books:

  • Vasef MA and Auerbach A, eds. In: Diagnostic Pathology: Molecular Oncology, Amirsys/Elsevier, Philadelphia, Pennsylvania, 2016.

  • Vasef MA (author) and Auerbach A (ed.) In: Diagnostic Pathology: Spleen, Amirsys Diagnostic Pathology Series, 2013.

  • Vasef MA (author) and Foucar K (ed.) In: Diagnostic Pathology: Blood and Bone Marrow. Amirsys Diagnostic Pathology Series, 2011.

  • Vasef MA, Platz CE. The Pathology of the Spleen. Bowdler Anthony J (ed.) In: The Complete Spleen: Structure, Function, and Clinical Disorders, 2nd Edition. Humana Press Inc., Totowa, NJ, 2001, Pg. 79-105.

Selected Publications:

  • Chabot-Richards D, Buehler K, Vasef MA. Detection of EGFR exon 19 E746-A750 deletion and EGFR exon 21 point mutations in lung adenocarcinoma by immunohistochemistry: a comparative study to EGFR exons 19 and 21 mutations analysis using PCR followed by high-resolution melting and pyrosequencing. Journal Histotechnol, 2015;38:56-62.

  • Kelley TW, Arber DA, Gibson C, Jones D, Khoury JD, Medeiros BC, O'Malley DP, Patel KP, Pilichowska M, Vasef MA, Wallentine J, Zehnder JL; Members of the Cancer Biomarker Reporting Committee, College of American Pathologists. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Myeloproliferative Neoplasms. Arch Pathol Lab Med. 2015 Dec 11. [Epub ahead of print] No abstract available. PMID:26653364

  • Kelley TW, Arber DA, Gibson C, Jones D, Khoury JD, Medeiros BC, O'Malley DP, Patel KP, Pilichowska M, Vasef MA, Wallentine J, Zehnder JL; Members of the Cancer Biomarker Reporting Committee, College of American Pathologists. Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1+). Arch Pathol Lab Med. 2015 Dec 11. [Epub ahead of print] No abstract available. PMID:26653363

  • O'Malley DP, Louissaint A Jr, Vasef MA, Auerbach A, Miranda R, Brynes RK, Fedoriw Y, Hudnall SD; International Spleen Consortium. Recommendations for gross examination and sampling of surgical specimens of the spleen. Ann Diagn Pathol. 2015 Oct;19(5):288-95. doi: 10.1016/j.anndiagpath.2015.06.004. Epub 2015 Jun 9. PMID:26143481

  • Cerhan JR, Natkunam Y, Morton LM, Maurer MJ, Asmann Y, Habermann TM, Vasef MA, Cozen W, Lynch CF, Allmer C, Slager SL, Lossos IS, Chanock SJ, Rothman A, Hartge P, Dogan A, Wang SS. LIM domain only 2 protein expressin, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. Leuk Lymphoma, Jan3, 2012 (Epub ahead of print).

  • Morton LM, Cerhan JR, Hartge P, Vasef MA, neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, Lynch CF, Rothman N, Chatherjee N, Yu K, Staudt M, Weisenburger DD, Wang SS. Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. Int J Mol Epidemiol Genet, 2:245-252, 2011.

  • Chang CM, Wang SS, Dave BJ, Jain S, Vasef MA, Weisenburger DD, Cozen W, Davis S, Severson RK, Lynch CF, Rothman N, Cerhan JR, Hartge P, Morton LM. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer. 129:938-947, 2011.

  • Garcia CF, Hunt KE, Kang H, Babb A, Gale JM, Vasef MA, Reichard KK. Most Morphologic Features in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) do not Reliably Predict Underlying FISH Genetics or Immunoglobulin Heavy Chain Variable Region Somatic Mutational Status. Appl Immunohistochem Mol Morphol. 18(2):119-27, 2010.

  • Worcester HD, Vasef MA. Therapy-Rrelated Acute Myeloid Leukemia with 11q23 abnormality Co-existing with Refractory Metastatic Ewing Sarcoma: Report of A Case and Review of the Literature. Pediatr Dev Pathol. 13(1):50-54, 2010.

  • Rosenbaum L, Fekrazad MH, Rabinowitz I, Vasef MA. Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. J Hematop, 2(2):127-131, 2009.

  • Schuetz MJ III, Zafar N, Vasef MA. Instances of mantle cell lymphoma morphologically mimicking other subtypes of B-cell lymphoid proliferation. South Med J, 102(4):369-373, 2009.

  • Wang HY, Ding J, Vasef M, and Wilson K. A bcr3/short form PML-RARα transcript in an acute promyelocytic leukemia resulted from a derivative chromosome 17 due to submicroscopic insertion of PML gene into RARα locus. Am J Clin Pathol 131(1):64-71, 2009.

Search PubMed:

Mohammad A. Vasef on PubMed